NCT06979427 CTFFR and Prediction of Non-Significant CAD Lesions
| NCT ID | NCT06979427 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Shiraz University of Medical Sciences |
| Condition | Chronic Coronary Syndrome |
| Study Type | INTERVENTIONAL |
| Enrollment | 250 participants |
| Start Date | 2024-01-01 |
| Primary Completion | 2026-07-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 250 participants in total. It began in 2024-01-01 with a primary completion date of 2026-07-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
In this prospective cohort study, 250 patients with suspected or known CAD and at least one intermediate coronary lesion (50-70% stenosis) who had a NiFFR value greater than 0.80 underwent coronary computed tomography angiography (CCTA) with NiFFR assessment. Patients were followed for one year to monitor for MACE
Eligibility Criteria
Inclusion Criteria: * Patients were enrolled if they had at least one intermediate coronary lesion (classified as 50-70% diameter stenosis on visual judgment) on CCTA and then underwent FFR testing Exclusion Criteria: * Patients having past coronary artery bypass graft surgery (CABG) * previous PCI in the target vascular * significant renal impairment define with eGFR \< 30 mL/min/1.73 m² * contrast allergy * poor image quality that prevented appropriate CCTA or CT-FFR analysis
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06979427 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, up to 80 Years, studying Chronic Coronary Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06979427 currently recruiting?
Yes, NCT06979427 is actively recruiting participants. Contact the research team at kojurij@yahoo.com for enrollment information.
Where is the NCT06979427 trial being conducted?
This trial is being conducted at Shiraz, Iran.
Who is sponsoring the NCT06979427 clinical trial?
NCT06979427 is sponsored by Shiraz University of Medical Sciences. The trial plans to enroll 250 participants.